The PhenoVue™ human IgG4 isotype control is used as a negative control for test antibodies of the same isotype. Compatible with both live-cell and fixed-cell protocols, it allows for more accurate assessment of background or non-specific binding. When processed in parallel at matching concentrations, it facilitates the interpretation of antibody internalization and signal specificity.
| Feature | Specification |
|---|---|
| Quantity | 1 |
The PhenoVue™ human IgG4 isotype control is used as a negative control for test antibodies of the same isotype. Compatible with both live-cell and fixed-cell protocols, it allows for more accurate assessment of background or non-specific binding. When processed in parallel at matching concentrations, it facilitates the interpretation of antibody internalization and signal specificity.
The PhenoVue Human IgG4 Isotype Control is a negative control for evaluation of antibody-mediated internalization. Compatible with both live-cell and fixed-cell protocols, it is processed in parallel with test antibodies of the same isotype to distinguish specific uptake from nonspecific background. This reagent is recommended for use with the PhenoVue Human IgG Antibody Internalization Kit (Fluor 647, pH-sensitive), where it provides the reference needed to validate signal specificity. Supplied in a 2 x 96-well format, it supports high-content imaging, immunofluorescence, and microscopy applications, for antibody and ADC research.
| Form |
Liquid
|
|---|
| Application |
High Content Imaging
Microscopy
|
|---|---|
| Assay Points |
2 x 96-well or 1 x 384-well microplates
|
| Brand |
PhenoVue™
|
| Detection Modality |
Fluorescence
|
| Product Group |
Antibody
|
| Quantity |
1
|
| Sample Type |
Live and fixed cells
|
| Shipping Conditions |
Shipped in Dry Ice
|
| Storage Conditions |
-16° C or below, protected from light
|
| Target Species |
Human
|
| Type |
Individual reagent
|
| Unit Size |
50 µL
|
Are you looking for resources, click on the resource type to explore further.
Internalization and trafficking to lysosomes are critical steps for the efficacy of antibody-based treatments, especially antibody...
We are here to answer your questions.